Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MRNA Moderna > Detailed Quotes

MRNA Moderna

122.250
+2.560+2.14%
Trading Session 09/27 12:43 ET
High
125.160
Open
120.580
Turnover
250.75M
Low
120.250
Pre Close
119.690
Volume
2.04M
Market Cap
47.82B
P/E(TTM)
3.72
52wk High
376.650
Shares
391.20M
P/E(Static)
4.32
52wk Low
115.610
Float Cap
44.00B
Bid/Ask %
-33.33%
Historical High
497.490
Shs Float
359.91M
Volume Ratio
0.87
Historical Low
11.540
Dividend TTM
--
Div Yield TTM
--
P/B
2.66
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.57%
Amplitude
4.10%
Avg Price
122.947
Lot Size
1
Float Cap
44.00B
Bid/Ask %
-33.33%
Historical High
497.490
Shs Float
359.91M
Volume Ratio
0.87
Historical Low
11.540
Dividend TTM
--
P/B
2.66
Dividend LFY
--
Turnover Ratio
0.57%
Amplitude
4.10%
Avg Price
122.947
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
CEO: Mr. Stephane Bancel
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...